Medications

Dotarem approved for nervous system MRIs

(HealthDay)—Dotarem (gadoterate meglumine) has been approved by the U.S. Food and Drug Administration as a contrast agent for use in MRIs of the brain, spine and other parts of the central nervous system.

Medical research

Researchers develop novel methods to observe disease processes

(Medical Xpress)—The ability to directly observe the body is an invaluable tool in the arsenal of any medical professional. In fact, physical inspection comes only second to discussion of symptoms and medical history in ...

Radiology & Imaging

Exploring ferumoxytol: A new frontier in MRI contrast agents

Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated for its non-ionizing and non-invasive nature. With nearly 40% of MRI procedures requiring contrast agents for optimal sensitivity, ...

page 8 from 10